Back to Search
SONYA NARULA, MD
MD
Internal Medicine Physician
NPI: 1386272714IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD61662890(WA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2020
Research & Publications (20)
Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
PMID 18995892·J Allergy Clin Immunol·2009
8-other
Experience with Kangaroo mother care in a neonatal intensive care unit (NICU) in Chandigarh, India.
PMID 19390999·Indian J Pediatr·2009
8-other
Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity.
PMID 19661245·Am J Respir Crit Care Med·2009
3-trial
SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity.
PMID 18179464·Chem Biol Drug Des·2008
8-other
Inferior mesenteric artery aneurysm with occlusion of the superior mesenteric artery, coeliac trunk and right renal artery.
PMID 17913522·Eur J Vasc Endovasc Surg·2008
5-case
The effect of fatigue on trunk muscle activation patterns and spine postures during simulated firefighting tasks.
PMID 18568962·Ergonomics·2008
8-other
Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution.
PMID 17521034·Ann Allergy Asthma Immunol·2007
5-case
Genetic screens for Caenorhabditis elegans mutants defective in left/right asymmetric neuronal fate specification.
PMID 17717195·Genetics·2007
7-preclinical
A 65-year-old woman with intractable nasal congestion.
PMID 16498848·Ann Allergy Asthma Immunol·2006
5-case
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
PMID 16492148·Chem Biol Drug Des·2006
4-observational
A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
PMID 16258021·J Pharmacol Exp Ther·2006
7-preclinical
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336.
PMID 16754676·J Biol Chem·2006
7-preclinical
Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.
PMID 15664857·Bioorg Med Chem Lett·2005
8-other
Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5.
PMID 15693002·Arthritis Rheum·2005
7-preclinical
Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.
PMID 15770697·Eur J Immunol·2005
7-preclinical
The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP.
PMID 15796906·Biochem Biophys Res Commun·2005
8-other
Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
PMID 16787325·Med Chem·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1959 NE PACIFIC ST.
SEATTLE, WA 98195 - Phone
- (206) 520-5000
Quick Facts
- NPI
- 1386272714
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile